Cargando…

Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data

INTRODUCTION: Thrombocytopenia, a common complication of chronic liver disease (CLD), adversely affects the treatment in patients requiring invasive procedures. Multiple pathophysiological mechanisms contribute to the development of thrombocytopenia; thus, its incidence could differ among CLD etiolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Manami, Tateishi, Ryosuke, Hiroi, Shinzo, Fujiwara, Masakazu, Kitanishi, Yoshitake, Iwasaki, Kosuke, Takeshima, Tomomi, Igarashi, Ataru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866341/ https://www.ncbi.nlm.nih.gov/pubmed/34928469 http://dx.doi.org/10.1007/s12325-021-02008-x

Ejemplares similares

Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease
por: Yoshida, Manami, et al.
Publicado: (2021)

Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
por: Kondoh, Yasuhiro, et al.
Publicado: (2022)

Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses
por: Kurazono, Kenji, et al.
Publicado: (2022)

Analysis of antihypertensive treatment using real-world Japanese data—the retrospective study of antihypertensives for lowering blood pressure (REAL) study
por: Ohishi, Mitsuru, et al.
Publicado: (2019)

Opioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study
por: Yoshida, Manami, et al.
Publicado: (2023)

Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
por: Shimizu, Eiko, et al.
Publicado: (2022)

Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan
por: Hosogaya, Naoki, et al.
Publicado: (2023)

Patient journey through cases of depression from claims database using machine learning algorithms
por: Kitanishi, Yoshitake, et al.
Publicado: (2021)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data
por: Hiroi, Shinzo, et al.
Publicado: (2016)

In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
por: Izumi, Chisato, et al.
Publicado: (2023)

Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database
por: Ogino, Mieko, et al.
Publicado: (2016)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
por: Bury, Loredana, et al.
Publicado: (2021)

Sialic acid and platelet count regulation: Implications in immune thrombocytopenia
por: Lee‐Sundlov, Melissa M., et al.
Publicado: (2022)

Effect of linezolid on platelet count in critically ill patients with thrombocytopenia
por: Tatsumi, Hiroomi, et al.
Publicado: (2023)

Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
por: Li, Na, et al.
Publicado: (2021)

Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
por: Lee, Ayoung, et al.
Publicado: (2020)

Vaccine‐induced immune thrombotic thrombocytopenia presenting with normal platelet count
por: Page, David, et al.
Publicado: (2021)

Reticulated Platelet Count as a Diagnostic Tool in Immune Thrombocytopenia (ITP)
por: Butt, Aqsa Javed, et al.
Publicado: (2023)

Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study
por: Odawara, Masato, et al.
Publicado: (2021)

Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis
por: Nishimura, Rimei, et al.
Publicado: (2021)

Laparoscopic splenectomy for immune thrombocytopenia in patients with a very low platelet count
por: Zychowicz, Anna, et al.
Publicado: (2018)

Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia
por: Grodzielski, Matías, et al.
Publicado: (2019)

Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
por: Bang, Soo-Mee, et al.
Publicado: (2021)

Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis
por: Nishimura, Rimei, et al.
Publicado: (2022)

Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
por: Ono, Yasuhisa, et al.
Publicado: (2020)

Correction of spurious low platelet counts by optical fluorescence platelet counting of BC-6800 hematology analyzer in EDTA-dependent pseudo thrombocytopenia patients
por: Bao, Yejiang, et al.
Publicado: (2020)

A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
por: Nagai, Yoshio, et al.
Publicado: (2021)

A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data
por: Kawachi, Izumi, et al.
Publicado: (2022)

Determination of optimal prevention strategy for COVID-19 based on multi-agent simulation
por: Fujita, Satoki, et al.
Publicado: (2022)

Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis
por: Koyama, Kansuke, et al.
Publicado: (2018)

Author Correction: Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
por: Lee, Ayoung, et al.
Publicado: (2020)

The association of platelet counts with development and treatment for retinopathy of prematurity – is thrombocytopenia a risk factor?
por: Choręziak, Aneta, et al.
Publicado: (2019)

Correlation study between platelet count, leukocyte count, nonhemorrhagic complications, and duration of hospital stay in dengue fever with thrombocytopenia
por: Jayanthi, Hari Kishan, et al.
Publicado: (2016)

Gut microbiota were altered with platelet count and red blood cell count in immune thrombocytopenia patients with different treatments
por: Rui, Xue, et al.
Publicado: (2023)

Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count
por: Saad, W. E., et al.
Publicado: (2014)

Publisher Correction: Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia
por: Grodzielski, Matías, et al.
Publicado: (2020)

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study
por: Seino, Yutaka, et al.
Publicado: (2012)

Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia
por: Choi, Hyoung Soo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_049l3qd9as997q11rh5lg2kqe1